Trial Profile
An open randomised trial of therapeutic role of homoharringtonine in acute promyelocytic leukemia.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 11 Sep 2009
Price :
$35
*
At a glance
- Drugs Omacetaxine mepesuccinate (Primary) ; Arsenic trioxide; Cytarabine; Daunorubicin; Mitoxantrone; Tretinoin
- Indications Acute promyelocytic leukaemia
- Focus Therapeutic Use
- 11 Sep 2009 New trial record